Moving from subjective symptoms to objective data and personalized care.
Pillar 5: Measurement and Care
Most medical decisions are based on population averages. Clinical guidelines come from large cohort studies. Biomarker reference ranges represent statistical distributions across populations. Treatments are standardized for broad patient groups. This approach has produced enormous medical progress. But it has an inherent limitation. Population averages cannot fully represent individual physiology.
Pillar 5: Measurement and Care
Once disease appears, modern medicine typically treats the symptoms. Blood pressure medications lower blood pressure. Anti-inflammatory drugs suppress inflammatory markers. Sleep medications induce sedation. Anti-anxiety medications dampen stress responses. These treatments can be valuable and often life-saving. But they usually target outputs of a dysregulated system, not the system itself.
Pillar 5: Measurement and Care
Most medicine detects disease late. Blood tests measure downstream biomarkers. Imaging detects organ damage. Clinical symptoms appear only after the body has already been under physiological stress for years. By the time most diseases are diagnosed, the underlying regulatory dysfunction has often been progressing silently. The problem is not that
Pillar 5: Measurement and Care
For decades, healthcare has focused on treating what is already broken. Blood tests flag abnormalities. Imaging reveals damage. Diagnoses are made once symptoms become impossible to ignore. By the time answers arrive, the body has often been compensating and struggling for years. But what if we could see problems earlier,